| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kala Bio, Inc. (KALA) has 7 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. KALA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 103.5K | $348.9K | - | |
| 10% | 46.5K | $156.6K | - | |
| Other | 41.8K | $140.7K | - | |
| Other | 36.0K | $121.2K | - | |
| Dir | 35.9K | $121.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2018 | Ra Capital Management, LLC53 | Director, 10% Owner | Buy | 2,424,242 | $8.25 | $19,999,996.50 | +114.7% | |
| Oct 3, 2018 | Shah Rajeev M. | Director, 10% Owner | Buy | 2,424,242 | $8.25 | $19,999,996.50 | +114.7% | |
| Feb 8, 2018 | Orbimed Advisors LLC67 | 10% Owner | Buy | 25,000 | $12.93 | $323,250.00 | +0.7% | |
| Feb 2, 2018 | Orbimed Advisors LLC67 | 10% Owner | Buy | 37,840 | $14.73 | $557,383.20 | +1.1% | |
| Feb 1, 2018 | Orbimed Advisors LLC67 | 10% Owner | Buy | 362,240 | $15.00 | $5,433,371.60 | +5.7% | |
| Jan 29, 2018 | Orbimed Advisors LLC67 | 10% Owner | Buy | 72,760 | $14.97 | $1,089,306.80 | +1.2% | |
| Jan 24, 2018 | Orbimed Advisors LLC67 | 10% Owner | Buy | 257,285 | $14.88 | $3,828,990.49 | +1.8% | |
| Jan 12, 2018 | Orbimed Advisors LLC67 | 10% Owner | Buy | 240,484 | $13.28 | $3,192,709.94 | +3.1% | |
| Jul 25, 2017 | Longitude Capital Partners Ii, LLC | 10% Owner | Buy | 215,000 | $15.00 | $3,225,000.00 | +10.5% | |
| Jul 25, 2017 | Orbimed Advisors LLC67 | 10% Owner, See Remarks | Buy | 319,333 | $15.00 | $4,789,995.00 | +15.5% |